Leading Financial Service Provider in India | Canara Bank Securities Ltd

Jagsonpal Pharmaceuticals Ltd.

Sep 12 BSE 240.90 ( -7.70 -3.10%)

Volume7810

Prev. Close
248.60

Open Price
253.60

Today's Low / High

239.25 253.60

Bid. Price (Qty.)0.00 (0)

Offer Price (Qty.)
0.00 (0)

52 Wk Low / High

152.34 328.02

Sep 12 NSE 240.40( -7.42 -2.99%)

Volume105531

Prev. Close
247.82

Open Price
246.90

Today's Low / High

238.50 251.44

Bid Price (Qty.)0.00 (0)

Offer Price (Qty.)
0.00 (0)

52 Wk Low / High

153.10 328.04

Market Cap. ( ₹ in Cr. )	1601.82	P/BV	8.12	Book Value ( ₹ )	29.59
52 Week High/Low ( ₹ )	328/153	FV/ML	2/1	P/E(X)	28.93
Book Closure	12/09/2025	EPS ( ₹ )	8.31	Div Yield (%)	1.04

Standalone

(₹ in Crs.)

Particulars	Mar 25	Mar 24	Mar 23	Mar 22	Mar 21
Months	12	12	12	12	12
Source Of Info (AR = Annual Report, PR = Press Release)	PR	AR	AR	AR	AR
FaceValue	2.00	5.00	5.00	5.00	5.00


INCOME
Revenue From Operations [Net]	268.72	208.70	236.71	226.10	187.95
Total Operating Revenues	268.72	208.70	236.71	226.10	187.95

Other Income	8.19	9.28	5.73	3.34	4.39
Total Revenue	276.91	217.98	242.45	229.43	192.34

EXPENSES
Cost Of Materials Consumed	18.34	22.10	31.21	40.42	38.63
Purchase Of Stock-In Trade	80.22	53.98	57.59	49.75	36.86
Changes In Inventories Of FG,WIP And Stock-In Trade	-2.13	3.90	4.30	5.61	5.28
Employee Benefit Expenses	64.13	48.49	56.42	57.68	53.98
Finance Costs	0.96	0.81	0.41	0.29	1.09
Provisions And Contingencies	0.00	0.77	0.00	0.00	0.00
Depreciation And Amortisation Expenses	8.13	1.66	1.21	1.53	0.51
Other Expenses	57.08	56.40	53.04	46.84	34.11
Total Expenses	226.73	188.11	204.18	202.11	170.47

Profit/Loss Before Exceptional, ExtraOrdinary Items And Tax	50.17	29.87	38.27	27.32	21.87

Exceptional Items	19.69	0.00	-3.46	0.00	0.00
Profit/Loss Before Tax	69.86	29.87	34.81	27.32	21.87

Tax Expenses-Continued Operations
Current Tax	14.50	7.56	7.63	7.40	6.05
Deferred Tax	0.00	-0.15	0.46	0.33	-1.23
Total Tax Expenses	14.50	7.41	8.09	7.73	4.81
Profit/Loss After Tax And Before ExtraOrdinary Items	55.36	22.46	26.72	19.59	17.06

Profit/Loss From Continuing Operations	55.36	22.46	26.72	19.59	17.06

Profit/Loss For The Period	55.36	22.46	26.72	19.59	17.06

OTHER INFORMATION

EARNINGS PER SHARE
Basic EPS (Rs.)	8.26	8.49	10.20	7.48	6.51
Diluted EPS (Rs.)	8.22	8.46	10.20	7.48	6.51

DIVIDEND AND DIVIDEND PERCENTAGE
Equity Share Dividend	0.00	13.10	0.00	10.48	2.62
Equity Dividend Rate (%)	125.00	100.00	100.00	80.00	20.00

Markets

Income Statement

INCOME STATEMENT

Jagsonpal Pharmaceuticals Ltd.